MetLife/$MET
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About MetLife
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
- Ticker
- $MET
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 46,000
- Headquarters
- New York, United States
- Website
- www.metlife.com
MetLife Metrics
BasicAdvanced
$60B
18.10
$5.22
0.76
$2.32
2.51%
Price and volume
Market cap
$60B
Beta
0.76
52-week high
$100.93
52-week low
$67.33
Average daily volume
3.1M
Dividend rate
$2.32
Financial strength
Current ratio
2.027
Quick ratio
1.705
Long term debt to equity
0.965
Total debt to equity
1.449
Dividend payout ratio (TTM)
46.36%
Interest coverage (TTM)
4.84%
Profitability
EBITDA (TTM)
6,040
Gross margin (TTM)
23.95%
Net profit margin (TTM)
4.57%
Operating margin (TTM)
6.64%
Effective tax rate (TTM)
24.85%
Revenue per employee (TTM)
$1,730,000
Management effectiveness
Return on assets (TTM)
0.45%
Return on equity (TTM)
13.09%
Valuation
Price to earnings (TTM)
18.101
Price to revenue (TTM)
0.778
Price to book
2.19
Price to tangible book (TTM)
3.36
Price to free cash flow (TTM)
4.016
Free cash flow yield (TTM)
24.90%
Free cash flow per share (TTM)
23.514
Dividend yield (TTM)
2.46%
Forward dividend yield
2.51%
Growth
Revenue change (TTM)
8.74%
Earnings per share change (TTM)
-11.97%
3-year revenue growth (CAGR)
4.34%
10-year revenue growth (CAGR)
1.67%
3-year earnings per share growth (CAGR)
10.54%
10-year earnings per share growth (CAGR)
3.19%
3-year dividend per share growth (CAGR)
4.34%
10-year dividend per share growth (CAGR)
4.17%
What the Analysts think about MetLife
Analyst ratings (Buy, Hold, Sell) for MetLife stock.
Analyst projections of the future price of MetLife stock.
Bulls say / Bears say
Adjusted earnings rose 15% in Q2 2026 and adjusted EPS rose 20%, while adjusted revenues excluding pension risk transfers grew 5% across every operating segment. That breadth suggests momentum is not confined to one business. (MetLife)
MetLife returned over $1.1 billion through buy-backs and dividends in Q2, and its board approved a further $3 billion share-repurchase authorisation. That gives shareholders a direct route to benefit from the company’s capital generation. (MetLife)
International growth offers another earnings engine: Asia adjusted earnings rose 21% in Q2, and management said Japanese demand for yen-denominated products was increasing, with those products reaching half of Japan sales. This could support further growth in a key market. (Reuters, Stock Analysis)
Some Group Benefits underwriting strength may be temporary: the group-life mortality ratio was 79%, below the 83%–88% target range, and management said roughly two points of Q2 favourability were not expected to repeat in the second half. Normalisation could remove part of the earnings support. (The Motley Fool, MetLife)
Market-related losses can obscure operating progress: Q2 net income rose only 1%, against 15% growth in adjusted earnings, after-tax investment losses of $338 million and derivative losses of $610 million. This makes reported results more sensitive to market movements. (MetLife)
The direct expense ratio increased to 12.1% in Q2 from 11.7% a year earlier. If cost growth continues, it could make it harder to preserve margins, even though MetLife says it remains on track for its full-year target. (MetLife)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.
MetLife Financial Performance
Revenues and expenses
MetLife Earnings Performance
Company profitability
Upcoming events
No upcoming events
MetLife News
AllArticlesVideos
Funds containing MetLife
AllEURUSDGBP
Fund name | Fund size | $MET weighting |
|---|---|---|
iShares Dow Jones U.S. Select Dividend€EXX5 | €412M | 1.34% |
iShares S&P 500 Financials Sector$IUFS | $2.4B | 0.67% |
iShares S&P 500 Financials Sector£UIFS | £1.8B | 0.67% |
iShares Ageing Population€AGED | €822M | 0.55% |
iShares Edge MSCI World Value Factor$IWVL | $7.4B | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.